๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura

โœ Scribed by F. Ferrara; C. Copia; M. Annunziata; A. Spasiano; C. Di Grazia; S. Palmieri; L. Prossomariti; G. Mele


Publisher
Springer
Year
1999
Tongue
English
Weight
65 KB
Volume
78
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of thrombotic thrombocytopenic
โœ Catherine Mazzei; Samuel Pepkowitz; Ellen Klapper; Dennis Goldfinger ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 23 KB ๐Ÿ‘ 2 views

Plasma exchange (PE) is considered first-line treatment for thrombotic thrombocytopenic purpura (TTP) to the point that many clinicians regard it as definitive therapy. Studies have reported response rates to PE ranging from 39% to 78%. In our experience, a minority of patients have been cured solel

Rituximab for treatment of refractory/re
โœ Afaq Ahmad; Anita Aggarwal; Daya Sharma; Harish P. Dave; Virginia Kinsella; Marg ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 2 views

## Abstract Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagul